To effectively respond to the COVID-19 outbreak, rapid detection of cases and contacts, appropriate clinical management and infection control, and implementation of community mitigation efforts are critical.
Read MoreLonghorn’s PrimeStore MTM is the only FDA-cleared nucleic transport device that inactivates microbes within the device allowing for safe transport and testing.
Read MorePurdue University biomedical engineers have developed a handheld paper device that could be used to detect the COVID-19 strain. But developing a process to manufacture it would cost at least a couple of million dollars.
Read More
The structure of the SARS-CoV-2 spike is similar to that of the coronavirus responsible for the 2003 global outbreak of severe acute respiratory syndrome.
Read More
The newly developed recombinant antigens derived specifically from COVID-19 are intended for use in infectious disease research, and assay and vaccine development.
Read More